CAR-T cell therapy in older adults with relapsed/refractory LBCL: benefits and challenges
Patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) have poor prognosis with a high unmet need for efficacious treatment options. Most patients with r/r large B-cell lymphoma (LBCL) are elderly, which adds to the complexity of choosing the appropriate and effective therapy...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2025-06-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Länkar: | https://jitc.bmj.com/content/13/6/e009793.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|